Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma.

Pluschnig, Ursula

Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma. [electronic resource] - Anticancer research Mar 2013 - 1035-9 p. digital

Publication Type: Journal Article

1791-7530


Adenocarcinoma--drug therapy
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Capecitabine
Deoxycytidine--administration & dosage
Epirubicin--administration & dosage
Esophagogastric Junction
Female
Fluorouracil--administration & dosage
Humans
Liver Neoplasms--secondary
Male
Middle Aged
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Palliative Care
Stomach Neoplasms--drug therapy